NCT07280403已完成不适用
Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss: a Pilot Trial
INQUIS Clinical Research1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年9月12日最近更新:
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Body weight
研究概览
简要总结
The goal of this clinical trial is to determine the effect of a low carbohydrate higher protein diet, modelled after the Atkins program on weight loss, glycemic control, risk markers of cardiovascular disease and body composition in patients taking semaglutide.
Participants will:
- Be randomized to follow either a low carb, higher protein diet or a low fat diet for 3 months.
- Visit the clinic at week 2, 4, 8 and 12 to meet with a dietician, fill out a symptoms questionnaire and for bloodwork
- Complete 3-day food records 4 times over the 12 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Aged 18-75 years, inclusive
- •Overweight or obese individuals with a BMI ≥26 kg/m²
- •Non-pregnant, non-lactating individuals who are not planning on becoming pregnant during the trial and are using an effective method of contraception, as outlined: (a) Complete abstinence from intercourse two weeks prior to administration of the study product, and throughout the clinical trial. Participants utilizing this method must agree to use 2 alternate methods of contraception (see d) if they should become sexually active and will be queried on whether they have been abstinent at each study visit. b) Has a male sexual partner who is surgically sterilized prior to the Screening Visit and is the only male sexual partner for that Participant; c) Sexual partner(s) is/are exclusively female; d) Use of two acceptable methods of contraception, such as a spermicide, mechanical barrier (e.g. male condom, female diaphragm), tubal ligation, contraceptive pill, intrauterine device (IUD) or contraceptive implant. The Participant must be using these methods for at least 1 week prior to the screening visit and throughout their participation in the trial.
- •Started semaglutide injections for weight loss 14 to 35 days prior to screening, inclusive, are tolerating it and are willing to continue taking it
- •HbA1c ≤7.5%
- •Not taking any hypoglycemic agent, apart from a semaglutide
- •Systolic blood pressure <160 mmHg and diastolic blood pressure <100 mmHg
- •Serum creatinine <180 mmol/L (<2.1 mg/dL)
- •Serum triglycerides <9 mmol/L (<800 mg/dL)
- •ALT or AST <3 times the upper limit of normal
- •Untreated LDL-cholesterol <5.00 mmol/l (<193 mg/dL)
- •No major illness, trauma or surgery requiring hospitalization within 3mo of the screening visit
- •Ability to understand the study procedures and willing to provide informed consent to participate in the study
- •Subjects must be eligible to receive income in Canada and be covered by a health insurance plan such as OHIP
- •Subjects are willing to sign the informed consent prior to any procedures conducted
排除标准
- •Failure to meet any one of the inclusion criteria
- •High alcohol consumption (>14 standard drinks per week or >4 standard drinks per day for males; and > 7 standard drinks per week or >3 standard drinks per day for females), with 1 standard drink defined as containing approximately 14g of pure alcohol. Examples of 1 standard drink include: 12 oz of regular beer (approx. 5% alcohol), 5 oz of wine (approx. 12% alcohol) or 1.5 oz of distilled spirits (approx. 40% alcohol)
- •Individuals with a history of bariatric surgery, gastrointestinal disease, any other medical conditions or use of supplements or medications that increase risk to the subject or others or may affect the results, as judged by the Principal Investigator
- •Unwillingness or inability to comply with the experimental procedures and to follow INQUIS safety guidelines
- •Known intolerance, sensitivity, or allergy to any ingredients in the study test products
- •Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement, or lifestyle modification
研究组 & 干预措施
Low Carbohydrate
Experimental
Subjects randomized to the low-carbohydrate arm will be instructed on a reduced calorie diet (<1400 kcal/day) consisting of an average macronutrient distribution of 20% carbohydrate, 30% protein and 50% fat with a maximum intake of 40g/day of available (net) carbohydrates (approximately 65-75g total carbohydrates). To complement the provided low carbohydrate shakes and snacks, dietary counselling will focus on choosing sources of protein and non-starchy vegetables
干预措施: Low Carbohydrate (Behavioral)
Low Fat
Active Comparator
Subjects randomized to the low-fat arm will be instructed on a reduced calorie diet (<1400 kcal/day) consisting of an average macronutrient distribution of 50% carbohydrate, 20% protein and 30% fat, with a maximum intake of 50g/day of fat. To complement the provided low fat shakes and snacks, dietary counselling will focus on choosing lean sources of protein and carbohydrates, while limiting high fat foods such as oils, nuts, full fat dairy, and fatty meats.
干预措施: Low Fat (Behavioral)
结局指标
主要结局
Body weight
时间窗: 12 weeks
Percentage change from baseline of body weight
次要结局
- BMI(12 weeks)
- Fat Mass(12 weeks)
- Fasting plasma glucose(12 weeks)
- Fat-free mass(12 weeks)
- Skeletal Muscle Mass(12 weeks)
- Fasting serum insulin(12 weeks)
- Insulin sensitivity index(12 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A randomised controlled trial of a reduced carbohydrate diet versus a low fat diet for the treatment of childhood obesity: the Eat Smart StudyNutritional, Metabolic, EndocrineChildhood obesityISRCTN49438757ational Heart Foundation (Australia)135
招募中
不适用
Higher protein, lower carbohydrate diet to reduce glycated haemoglobin (HbA1c)Diabetes mellitus (type 2)Metabolic and Endocrine - DiabetesDiet and Nutrition - ObesityACTRN12612000676819Baker IDI Heart & Diabetes Institute100
已完成
不适用
The effect of very low carbohydrate and high fat diet on gastric cancerGastric cancer.Malignant neoplasm of stomachIRCT2016102830538N1Vice chancellor of research, International Campus, Tehran University of Medical Sciences20
尚未招募
不适用
ow Carbohydrate Diet & Blood Sugar Control in Joint ReplacementHyperglycaemiaSurgery - Other surgeryDiet and Nutrition - ObesityMetabolic and Endocrine - Other metabolic disordersMusculoskeletal - OsteoarthritisOsteoarthritisObesityACTRN12620000003976Perth Orthopaedic & Sports Medicine Research Institute46
已完成
3 期
Effect of diet therapy in treatment of Coronary Heart DiseaseCoronary Heart Disease.Ischaemic heart disease (chronic) NOSI25.9IRCT201601025623N61Vice chancellor for research, Kashan University of Medical Sciences56